We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Jz Capital Partners Limited | LSE:JZCP | London | Ordinary Share | GG00B403HK58 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 215.00 | 192.00 | 238.00 | 219.00 | 215.00 | 215.00 | 0.00 | 08:00:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 22.2M | 2.65M | 0.0342 | 62.87 | 166.58M |
TIDMJZCP TIDMJZCC TIDMJZCN JZ CAPITAL PARTNERS TO REALISE GAIN - NAV UPLIFT OF 4.3% 12 March 2018 JZ Capital Partners Limited (LSE:JZCP.L or "JZCP"), the London listed fund that invests in US and European microcap companies and US real estate, is pleased to announce an agreement to sell Bolder Healthcare Solutions ("BHS") to a subsidiary of Cognizant, one of the world's leading professional services companies. Headquartered in Louisville, Kentucky, BHS offers a full suite of healthcare revenue cycle management services to the hospital and physician marketplace in the United States. BHS was formed through a co-investment partnership between JZCP and the Edgewater Funds. JZCP will realise approximately $108.0 million in gross proceeds from this sale, representing an increase in net asset value ("NAV") of approximately $35.1 million, or 4.3% of NAV, as of January 31, 2018. David Zalaznick, JZCP's Founder and Investment Adviser, commented: "This will be a significant transaction that demonstrates JZCP's ability to consistently realise key assets at, or above, NAV. Our CEO, Mike Shea, and his management team at BHS did a superb job and we appreciate all their efforts that made this such a successful transaction." Completion of the transaction is subject to customary closing conditions and regulatory approvals, including The Hart-Scott-Rodino Antitrust Improvements Act of 1976. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 Ends For further information: Ed Berry / Kit Dunford +44 (0) 20 3727 1143 FTI Consulting David Zalaznick +1 212 485 9410 Jordan/Zalaznick Advisers, Inc. Paul Ford +44 (0) 1481 745383 JZ Capital Partners About JZCP JZ Capital Partners ("JZCP") is one of the oldest closed-end investment companies listed on the London Stock Exchange. It seeks to provide shareholders with a return by investing selectively in US and European microcap companies and US real estate. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. ("JZAI") which is led by David Zalaznick and Jay Jordan. They have worked together for more than 35 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI's experts work with the existing management of microcap companies to help build better businesses, create value and deliver strong returns for investors. For more information please visit www.jzcp.com. END
(END) Dow Jones Newswires
March 12, 2018 07:05 ET (11:05 GMT)
1 Year Jz Capital Partners Chart |
1 Month Jz Capital Partners Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions